- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 24
  num_fold: 3874
  S: 3069
  I: 721
  R: 84
  median_fold: 1.9
  percent: 5.9
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 21
  num_fold: 1048
  S: 790
  I: 222
  R: 36
  median_fold: 2.5
  percent: 1.6
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 152
  num_fold: 16196
  S: 11829
  I: 3499
  R: 868
  median_fold: 2.5
  percent: 25.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 36
  num_fold: 2024
  S: 1304
  I: 639
  R: 81
  median_fold: 3.1
  percent: 3.1
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 47
  num_fold: 3462
  S: 2202
  I: 1010
  R: 250
  median_fold: 3.9
  percent: 5.3
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 6
  num_fold: 171
  S: 119
  I: 43
  R: 9
  median_fold: 3.8
  percent: 0.26
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.24
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.021
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 60
  num_fold: 7874
  S: 5669
  I: 1937
  R: 268
  median_fold: 3.3
  percent: 12.0
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 8
  num_fold: 354
  S: 250
  I: 84
  R: 20
  median_fold: 3.1
  percent: 0.54
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 16
  num_fold: 2405
  S: 2120
  I: 263
  R: 22
  median_fold: 2.8
  percent: 3.7
  priority: 2
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 8
  num_fold: 838
  S: 408
  I: 177
  R: 253
  median_fold: 6.3
  percent: 1.3
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 43
  S: 41
  I: 2
  R: 0
  median_fold: 2.1
  percent: 0.066
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 31
  num_fold: 1782
  S: 1064
  I: 490
  R: 228
  median_fold: 4.0
  percent: 2.7
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 11
  num_fold: 310
  S: 250
  I: 57
  R: 3
  median_fold: 1.5
  percent: 0.48
  priority: 3
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 342
  S: 96
  I: 246
  R: 0
  median_fold: 6.8
  percent: 0.52
  priority: 3
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 9
  num_fold: 609
  S: 324
  I: 164
  R: 121
  median_fold: 1.8
  percent: 0.93
  priority: 6
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 3
  num_fold: 42
  S: 29
  I: 10
  R: 3
  median_fold: 3.0
  percent: 0.064
  priority: 6
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 142
  S: 28
  I: 114
  R: 0
  median_fold: 5.7
  percent: 0.22
  priority: 6
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 81
  S: 70
  I: 11
  R: 0
  median_fold: 1.3
  percent: 0.12
  priority: 7
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 318
  S: 213
  I: 101
  R: 4
  median_fold: 1.7
  percent: 0.49
  priority: 8
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 499
  S: 100
  I: 398
  R: 1
  median_fold: 20.0
  percent: 0.76
  priority: 8
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.73
  priority: 9
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 172
  S: 152
  I: 0
  R: 20
  median_fold: 2.4
  percent: 0.26
  priority: 9
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 134
  S: 134
  I: 0
  R: 0
  median_fold: 4.3
  percent: 0.21
  priority: 10
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 70
  S: 2
  I: 68
  R: 0
  median_fold: 8.0
  percent: 0.11
  priority: 10
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 14
  num_fold: 1784
  S: 1227
  I: 543
  R: 14
  median_fold: 3.3
  percent: 2.7
  priority: 10
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 6
  num_fold: 214
  S: 106
  I: 68
  R: 40
  median_fold: 5.4
  percent: 0.33
  priority: 10
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 7
  num_fold: 912
  S: 425
  I: 487
  R: 0
  median_fold: 5.1
  percent: 1.4
  priority: 10
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 404
  S: 253
  I: 151
  R: 0
  median_fold: 3.6
  percent: 0.62
  priority: 10
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 166
  S: 110
  I: 43
  R: 13
  median_fold: 2.6
  percent: 0.25
  priority: 11
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 64
  S: 40
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.098
  priority: 13
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 483
  S: 311
  I: 130
  R: 42
  median_fold: 3.1
  percent: 0.74
  priority: 14
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 16
  num_fold: 872
  S: 666
  I: 144
  R: 62
  median_fold: 2.4
  percent: 1.3
  priority: 15
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 7
  num_fold: 180
  S: 130
  I: 44
  R: 6
  median_fold: 2.6
  percent: 0.28
  priority: 15
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 306
  S: 196
  I: 109
  R: 1
  median_fold: 3.6
  percent: 0.47
  priority: 15
- vaccine: mRNA-1273 + mRNA-1273.351
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 237
  S: 222
  I: 11
  R: 4
  median_fold: 2.2
  percent: 0.36
  priority: 18
- vaccine: mRNA-1273 + mRNA-1273.211
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 4840
  S: 4808
  I: 32
  R: 0
  median_fold: 2.7
  percent: 7.4
  priority: 19
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 13
  S: 0
  I: 10
  R: 3
  median_fold: 15.0
  percent: 0.02
  priority: 25
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 142
  S: 42
  I: 82
  R: 18
  median_fold: 6.6
  percent: 0.22
  priority: 31
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 451
  S: 352
  I: 97
  R: 2
  median_fold: 1.6
  percent: 0.69
  priority: 34
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 6
  S: 6
  I: 0
  R: 0
  median_fold: 0.65
  percent: 0.0092
  priority: 39
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 108
  S: 80
  I: 28
  R: 0
  median_fold: 3.9
  percent: 0.17
  priority: 39
- vaccine: AZD1222 + mRNA
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 60
  S: 0
  I: 52
  R: 8
  median_fold: 9.4
  percent: 0.092
  priority: 100
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: infected
  num_ref_name: 7
  num_fold: 654
  S: 479
  I: 114
  R: 61
  median_fold: 2.6
  percent: 1.0
  priority: 1000
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 4
  num_fold: 358
  S: 271
  I: 79
  R: 8
  median_fold: 2.8
  percent: 0.55
  priority: 1000
